UPB 8-K 2026-11-10

Upstream Bio, Inc. (UPB) 8-K dated 2026-11-10 — accession 0001193125-26-454405.

Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.

Upstream Bio, Inc. filed a 8-K on 2026-11-10. Accession 0001193125-26-454405.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported UPB revenue for 2025-12-31 was $2.9M. Net income was -$143.4M. Revenue was up 20.4% from 2024-12-31 to 2025-12-31. UPB currently screens at market cap $407.3M.

Not investment advice. The UPB SEC hub lists recent forms. The stock page is the research view.